The trademark application WAINZUA was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on October 26, 2023, and it was registered by office on February 2, 2024 without any oppositions.
The application was filed in English (German was selected as the second language).